Clinical-scale manufacturing of γδ T cells for protection against infection and disease recurrence following haploidentical peripheral blood stem cell transplantation and cyclophosphamide gvhd prophylaxis.
Lawrence S LambSailesh PillaiSamantha LangfordJoscelyn BowersockAntonio Di StasiAyman SaadPublished in: Bone marrow transplantation (2018)